Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:16:41 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



Z:GKOS - GLAUKOS CORPORATION - http://www.glaukos.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GKOS - Z1.096.66·96.790.196.725-0.475-0.5169.716,0602,78096.49  97.45  96.29103.66  45.3814:58:00Apr 1615 min RT 2¢

Recent Trades - Last 10 of 2780
Time ETExPriceChangeVolume
14:58:06Z96.66-0.542
14:58:00Z96.68-0.521
14:57:53Z96.725-0.4751
14:57:11Z96.8353-0.3647100
14:57:01Z96.68-0.521
14:56:56Z96.725-0.475100
14:56:39Z96.66-0.541
14:56:21Z96.67-0.531
14:55:50Z96.65-0.55100
14:55:38Z96.715-0.485100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-16 16:05U:GKOSNews ReleaseGlaukos Announces the Release of its 2023 Sustainability Report
2024-04-10 07:00U:GKOSNews ReleaseGlaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
2024-04-03 07:00U:GKOSNews ReleaseGlaukos Receives Permanent J-code for iDose(TM) TR (travoprost intracameral implant)
2024-04-01 07:00U:GKOSNews ReleaseGlaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
2024-02-21 16:05U:GKOSNews ReleaseGlaukos Announces Fourth Quarter and Full Year 2023 Financial Results
2024-01-31 07:00U:GKOSNews ReleaseGlaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
2024-01-09 07:00U:GKOSNews ReleaseGlaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
2023-12-20 07:00U:GKOSNews ReleaseGlaukos Announces Participation in the J.P. Morgan Healthcare Conference
2023-12-14 07:00U:GKOSNews ReleaseGlaukos Announces FDA Approval of iDose ‚ ® TR (travoprost intracameral implant)
2023-11-07 07:00U:GKOSNews ReleaseGlaukos Announces Participation in Stifel Healthcare Conference
2023-11-01 16:05U:GKOSNews ReleaseGlaukos Announces Third Quarter 2023 Financial Results
2023-10-31 07:00U:GKOSNews ReleaseGlaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
2023-10-11 07:00U:GKOSNews ReleaseGlaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
2023-08-23 07:00U:GKOSNews ReleaseGlaukos Announces Participation in Wells Fargo Healthcare Conference
2023-08-02 16:05U:GKOSNews ReleaseGlaukos Announces Second Quarter 2023 Financial Results
2023-07-17 07:00U:GKOSNews ReleaseGlaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
2023-07-12 07:00U:GKOSNews ReleaseGlaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
2023-06-05 07:00U:GKOSNews ReleaseGlaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
2023-05-24 07:00U:GKOSNews ReleaseGlaukos Announces Participation in the William Blair Growth Stock Conference
2023-05-05 16:05U:GKOSNews ReleaseGlaukos Announces FDA Acceptance of NDA Submission for iDose TR